Journal for ImmunoTherapy of Cancer (Nov 2023)

401 GDA-201, nicotinamide (NAM) expanded NK cells derived from peripheral apheresis, show unique culture kinetics and increased expansion

Dima Yackoubov,
Ronit Simantov,
Yona Geffen,
Avishay Edri,
Avner Yeffet,
Isabelle Solomon,
Moriya Gamliel,
Yaron Meirow,
Eliran Arbib,
Yael Yoffe-Mizrahi

Affiliations

Dima Yackoubov: 1Gamida-Cell, Jerusalem, Israel
Ronit Simantov: 1Gamida-Cell, Jerusalem, Israel
Yona Geffen: 1Gamida-Cell, Jerusalem, Israel
Avishay Edri: 1Gamida-Cell, Jerusalem, Israel
Avner Yeffet: Gamida Cell Ltd., Jerusalem, Israel
Isabelle Solomon: Gamida Cell Ltd., Jerusalem, Israel
Moriya Gamliel: Gamida Cell Ltd., Jerusalem, Israel
Yaron Meirow: Gamida Cell Ltd., Jerusalem, Israel
Eliran Arbib: Gamida Cell Ltd., Jerusalem, Israel
Yael Yoffe-Mizrahi: Gamida Cell Ltd., Jerusalem, Israel

DOI: https://doi.org/10.1136/jitc-2023-SITC2023.0401
Journal volume & issue: Vol. 11, no. Suppl 1

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal